Security
LONGEVITY HEALTH HLDGS INC COM NEW · XAGE
XAGEOTCCommon stockCurrentCIK 1842939Updated Oct 6, 2026
Name history
Carmell Corp · through Feb 13, 2025ALPHA HEALTHCARE ACQUISITION CORP III · through Jul 20, 2023
XAGE price & chart
Loading TradingView…
OTC:XAGE on TradingView ↗About the company
Longevity is a bio-aesthetics company focused on longevity and healthy aging. Longevity has two cosmetic product lines, Elevai Exosomes™ and Carmell Secretome™, that support skin and hair health. All of Longevity's cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. Longevity sells its products in the United States through three distinct channels: business-to-business, direct-to-consumer, and distributor sales.
In the news
No coverage from other publishers is available.
Recent filings
424B3 filing
Other Events
Items 8.01, 9.01
424B3 filing
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
424B3 filing
Show 5 more recent filings
Other Events
Items 8.01, 9.01
424B3 filing
424B3 filing
10-Q filing
Entry into a Material Definitive Agreement · Termination of a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other Events
Items 1.01, 1.02, 2.03, 3.02, 5.02, 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 3,298,979Source | 2,441,854Source | 1,055,248Source | 3,719,342Source | 5,033,855Source | 1,642,393Source | 3,337,234Source | 6,180,343Source | 2,367,027Source | 1,473,980Source | 63,948,803Source | 156,978,800Source |
| Property, Plant and Equipment, NetUSD | 116,754Source | 131,216Source | 75,517Source | 117,662Source | 148,049Source | 87,719Source | 138,709Source | 170,447Source | 101,621Source | 113,906Source | 192,846Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 1,137,325Source | 35,471Source | — | 2,198,275Source | 313,396Source | — | 892,161Source | 706,740Source | — | 2,912,461Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 46,522Source | — | 19,546Source | 54,496Source | — | 48,665Source | 94,753Source | — | 36,500Source | 4,096Source | — | — |
| Inventory, NetUSD | 1,013,368Source | 97,890Source | 606,668Source | 1,172,634Source | 113,872Source | 734,968Source | 1,379,640Source | — | 963,028Source | 108,705Source | — | — |
| Assets, CurrentUSD | 2,843,947Source | 1,884,889Source | 711,716Source | 3,240,887Source | 4,101,006Source | 1,262,777Source | 2,793,177Source | 5,189,224Source | 1,950,091Source | 955,554Source | 62,900,114Source | 285,202Source |
| Operating Lease, Right-of-Use AssetUSD | 322,047Source | 404,971Source | 255,193Source | 343,426Source | 762,877Source | 277,939Source | 386,844Source | 797,617Source | 300,221Source | 384,879Source | 831,656Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 7,276,342Source | 6,506,411Source | 9,754,695Source | 7,456,876Source | 6,405,627Source | 8,537,309Source | 7,142,519Source | 7,572,002Source | 8,233,900Source | 6,186,642Source | 39,199,793Source | 7,086,950Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | — | — | 0Source | — | 0Source | 0Source | — | 0Source | 0Source | 1Source | 0Source |
| Common Stock, Value, IssuedUSD | 178Source | 2,091Source | 247Source | 148Source | 2,091Source | 247Source | 100Source | 1,936Source | 178Source | 2,091Source | 2,309Source | — |
| Additional Paid in CapitalUSD | 69,716,181Source | 63,890,731Source | 70,392,253Source | 68,526,285Source | 63,705,035Source | 70,313,494Source | 66,572,144Source | 60,380,765Source | 69,909,893Source | 64,156,909Source | 83,250,101Source | 0Source |
| Retained Earnings (Accumulated Deficit)USD | -73,693,722Source | -67,957,379Source | -79,091,947Source | -72,263,967Source | -65,078,898Source | -77,208,657Source | -70,377,529Source | -61,774,360Source | -75,776,944Source | -68,871,662Source | -58,503,401Source | -6,018,111Source |
| Stockholders' Equity Attributable to ParentUSD | -3,977,363Source | -4,064,557Source | -8,699,447Source | -3,737,534Source | -1,371,772Source | -6,894,916Source | -3,805,285Source | -1,391,659Source | -5,866,873Source | -4,712,662Source | 24,749,010Source | -6,017,679Source |
| Liabilities and EquityUSD | 3,298,979Source | 2,441,854Source | 1,055,248Source | 3,719,342Source | 5,033,855Source | 1,642,393Source | 3,337,234Source | 6,180,343Source | 2,367,027Source | 1,473,980Source | 63,948,803Source | 156,978,800Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 6,840,994Source | 6,173,838Source | 9,593,113Source | 6,913,648Source | 5,777,678Source | 8,349,146Source | 6,598,913Source | 6,905,552Source | 7,916,259Source | 5,876,705Source | 38,502,078Source | 1,681,514Source |
| Operating Lease, Liability, CurrentUSD | 93,314Source | 86,163Source | 99,065Source | 91,473Source | 149,503Source | 97,110Source | 113,573Source | 146,552Source | 95,193Source | 87,898Source | 150,136Source | — |
| Accounts Payable, CurrentUSD | 4,171,099Source | 4,214,294Source | 5,039,806Source | 4,590,542Source | 4,095,418Source | 5,046,277Source | 4,598,791Source | 4,283,470Source | 4,494,923Source | 4,058,091Source | 4,417,234Source | — |
| Operating Lease, Liability, NoncurrentUSD | 239,259Source | 332,573Source | 161,582Source | 263,290Source | 627,949Source | 188,163Source | 288,615Source | 666,450Source | 214,745Source | 309,937Source | 697,715Source | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 1,258,337Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -1,431,713Source | -1,505,867Source | -6,905,282Source | -10,650,464Source | -16,205,252Source | 204,997Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 16,268Source | 17,978Source | — | — | 15,038Source | 23,952Source | 78,675Source | 83,486Source | 97,113Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 145,927Source | 114,829Source | 692,790Source | 827,043Source | 667,682Source | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 12,165Source | 14,102Source | -44,151Source | 4,096Source | — | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -31,376Source | -15,204Source | -370,853Source | 108,705Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 551,354Source | 317,040Source | 126,858Source | -359,143Source | -449,873Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -485,291Source | -752,953Source | -3,329,266Source | -4,388,948Source | -8,348,208Source | -488,743Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | -150,000Source | -164,225Source | -748,796Source | -30,470Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | 14,225Source | — | 30,470Source | — |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 91,947Source | 1,515,861Source | 4,043,092Source | 2,382,422Source | 11,162,990Source | -97,785Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 1,109,228Source | 1,137,325Source | — | 1,551,199Source | 313,396Source | 770,047Source | 706,740Source | 157,139Source | 2,912,461Source | 187,664Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 3,450Source | 4,993Source | 18,214Source | 29,466Source | 283,526Source | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 265,576Source | — | 750,000Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 189,926Source | 185,696Source | 78,759Source | 194,323Source | 145,927Source | 114,829Source | 692,790Source | 827,043Source | 667,682Source | — |
| Amortization of Intangible AssetsUSD | — | — | 1,136Source | 1,145Source | — | 1,137Source | — | 1,137Source | 4,547Source | — | — | — |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of TaxUSD | — | — | — | — | — | — | — | — | — | 1,434,479Source | — | — |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | — | — | — | — | — | — | — | — | 826,980Source | — |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | — | — | — | — | — | — | -1,434,479Source | — | — |
| Gain (Loss) on Termination of LeaseUSD | — | — | 0Source | -44,577Source | — | — | — | — | 0Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | -44,577Source | 0Source | — |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | 0Source | 0Source | 0Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | -1,505,867Source | — | -10,650,464Source | -16,205,252Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -1,429,755Source | -2,878,481Source | — | -1,886,438Source | — | -1,505,867Source | -6,905,282Source | -10,650,464Source | -16,205,252Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | -1,152,276Source | 760,165Source | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 36,262Source | -97,279Source | 0Source | 391,198Source |
| Inventory Write-downUSD | — | — | 47,082Source | 0Source | 38,917Source | 0Source | 196,684Source | 0Source | 60,963Source | 4,754,357Source | 4,754,357Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,429,755Source | -2,878,481Source | -1,883,290Source | -1,886,438Source | -1,431,713Source | -1,505,867Source | -6,905,282Source | -10,368,261Source | -15,445,087Source | 204,997Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -2,878,481Source | — | — | — | — | — | -10,368,261Source | -16,121,110Source | — |
| Nonoperating Income (Expense)USD | — | — | 41,262Source | -1,458,692Source | -1,159,140Source | -27,834Source | -103,221Source | 884Source | 238,553Source | -5,749,245Source | -10,261,696Source | — |
| Operating ExpensesUSD | — | — | 1,725,480Source | 1,435,468Source | 959,686Source | 2,161,262Source | 1,565,517Source | 1,776,574Source | 8,202,333Source | 5,042,459Source | 5,943,556Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 190,001Source | 1,637,610Source | 3,483,790Source | 2,687,225Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | 41,073Source | — |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | 0Source | — | — | — | — | — | 0Source | 826,980Source | — |
| Depreciation | — | — | —Source | —Source | —Source | —Source | — | — | — | — | — | — |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| General and Administrative Expense | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Other Nonoperating Income (Expense) | — | — | — | —Source | —Source | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 425,864Source | 20,519Source | 395,991Source | 503,612Source | 391,764Source | 510,353Source | 1,912,811Source | 50,318Source | — | — |
| Cost of RevenueUSD | — | — | 171,401Source | 4,840Source | 160,455Source | 200,954Source | 154,739Source | 240,530Source | 818,051Source | 6,357Source | — | — |
| Operating Income (Loss)USD | — | — | -1,471,017Source | -1,419,789Source | -724,150Source | -1,858,604Source | -1,328,492Source | -1,506,751Source | -7,107,573Source | -4,998,498Source | -5,943,556Source | -5,507,641Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,429,755Source | -2,878,481Source | -1,883,290Source | -1,886,438Source | -1,431,713Source | -1,505,867Source | -6,869,020Source | -10,747,743Source | -16,205,252Source | -9,051,334Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 36,262Source | -97,279Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,429,755Source | -2,878,481Source | -1,883,290Source | -1,886,438Source | -1,431,713Source | -1,505,867Source | -6,905,282Source | -10,368,261Source | -15,445,087Source | -9,051,334Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.83Source | -4.13Source | -0.76Source | -1.56Source | -0.75Source | -1.52Source | -4.83Source | -0.49Source | -1.46Source | -5.47Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.83Source | -4.13Source | — | -1.56Source | -0.75Source | -1.52Source | -4.83Source | -0.49Source | -1.46Source | -5.47Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,723,434Source | 696,847Source | 2,475,321Source | 1,209,809Source | 1,899,910Source | 991,210Source | 1,429,557Source | 21,362,735Source | 11,021,167Source | 1,756,817Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,723,434Source | 696,847Source | — | 1,209,809Source | 1,899,910Source | 991,210Source | 1,429,557Source | 21,362,735Source | 11,021,167Source | 1,756,817Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 1,136Source | 1,145Source | — | 1,137Source | — | 1,137Source | 4,547Source | — | — | — |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | — | — | — | — | — | — | — | — | — | — | 826,980Source | 1,259,287Source |
| Gross ProfitUSD | — | — | 254,463Source | 15,679Source | 235,536Source | 302,658Source | 237,025Source | 269,823Source | 1,094,760Source | 43,961Source | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | -1,505,867Source | — | -10,650,464Source | -16,205,252Source | -9,051,334Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -1,429,755Source | -2,878,481Source | — | -1,886,438Source | — | -1,505,867Source | -6,905,282Source | -10,650,464Source | -16,205,252Source | -9,051,334Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.83Source | -4.13Source | — | -1.56Source | — | -1.52Source | -4.83Source | -0.5Source | -1.53Source | -5.47Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -0.83Source | -4.13Source | — | -1.56Source | — | -1.52Source | -4.83Source | -0.5Source | -1.53Source | -5.47Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | -1,152,276Source | 760,165Source | 0Source |
| Interest ExpenseUSD | — | — | 5,059Source | 7,123Source | — | 2,561Source | 3,450Source | 4,993Source | 18,214Source | 29,446Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -2,878,481Source | — | — | — | — | — | -10,368,261Source | -16,121,110Source | -9,607,835Source |
| Nonoperating Income (Expense)USD | — | — | 41,262Source | -1,458,692Source | -1,159,140Source | -27,834Source | -103,221Source | 884Source | 238,553Source | -5,749,245Source | -10,261,696Source | -3,543,693Source |
| Operating ExpensesUSD | — | — | 1,725,480Source | 1,435,468Source | 959,686Source | 2,161,262Source | 1,565,517Source | 1,776,574Source | 8,202,333Source | 5,042,459Source | 5,943,556Source | 5,507,641Source |
| Other IncomeUSD | — | — | 7,299Source | 13,145Source | — | 4,357Source | 860Source | 5,877Source | 168,146Source | 44,798Source | 68,772Source | 10,922Source |
| Research and Development ExpenseUSD | — | — | 227,993Source | 331,806Source | 73,351Source | 228,606Source | 55,488Source | 196,912Source | 788,888Source | 1,054,310Source | 2,497,218Source | 2,196,063Source |
| Selling and Marketing ExpenseUSD | — | — | 358,535Source | 120,062Source | 191,438Source | 345,505Source | 270,637Source | 280,549Source | 1,423,045Source | 189,323Source | — | — |
| Other Nonoperating Income (Expense) | — | — | — | —Source | —Source | —Source | — | — | — | — | — | — |
| Depreciation, Depletion and Amortization, Nonproduction | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| General and Administrative Expense | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Interest Income (Expense), Nonoperating, Net | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
Filing attachments
xage-ex99_1.htm · 8-K · 2026-03-17
EX-99.1 4 xage-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth PITTSBURGH, PA, March 17, 2026 - Longevity Health Holdings, Inc. (OTCQB: XAGE) ("Longevity" or the "Company") announced that its Board of Directors has appointed Ram Ajjarapu as Chairman and Chief Executive Officer, effective as of March 16, 2026. "Ram brings a strong track record of scaling busines…
Read attachment ↗